Updates in NHL Management 17+

Med Learning Group

专为 iPad 设计

    • 免费

简介

In the management of non-Hodgkin lymphoma (NHL), multiple mechanisms of therapy have been developed. These therapies include anti-CD20 antibodies and chimeric antigen receptor T-cell (CAR-T) therapies. With continued developments in NHL management, bispecific antibodies are a promising strategy for use in the relapsed/refractory setting with promising data showing potential for improving outcomes in patient care.

App 隐私

开发者“Med Learning Group”已表明该 App 的隐私规范可能包括了下述的数据处理方式。有关更多信息,请参阅开发者隐私政策

未收集数据

开发者不会从此 App 中收集任何数据。

隐私处理规范可能基于你使用的功能或你的年龄等因素而有所不同。了解更多

更多来自此开发人员的 App

Diabetic Retinopathy AR
医疗
SGLT2 & GLP-1 in Diabetes
医疗
Managing Atopic Dermatitis
医疗
AMD & Anti-VEGF Therapy
医疗
Non-Small-Cell Lung Cancer
医疗
CV Augmented Reality
教育

你可能也会喜欢

Hodgkin Lymphoma Manager
医疗
GeneBridge
医疗
ArepaSports
健康健美
Symptoms Tracker
医疗
Alamy
医疗
OncDoc
医疗